RE:RE:RE:AGM Perspectivessah1 wrote: I am very happy to stand corrected:-. What PPPS capacity will be required to generate the $8B/yr as this will be a critical factor as well in terms of timeframe?
Hi Sah1, like I said in a previous post, I asked the question to Pierre at the AGM and he came back with the explanation that Bruce Pritchard gave us with PLI's own capacity and the CMO's but that's about it.
I asked Fred the rough price of PG/L. and he answered around $ 1000 U.S./L. and with the graph presented on the capacity and revenue, it fits pretty well for PG deficiency but I think that it will be more valuable for Wound healing and other indications where micrograms are needed instead of milligrams. So I think the surprise will come from there. The revenue curve will expand vertically with the acute indications vs the needed quantity for PG deficiency.So nobody has the answer for now. For sure, from what Fred.told me,this part will be too large and PLI will need to partner PG for these indications. Exciting times ahead.